File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Treatment of Postrenal Transplantation Lymphoproliferative Disease Manifesting as Plasmacytoma with Nonmyeloablative Hematopoietic Stem Cell Transplantation from the Same Kidney Donor

TitleTreatment of Postrenal Transplantation Lymphoproliferative Disease Manifesting as Plasmacytoma with Nonmyeloablative Hematopoietic Stem Cell Transplantation from the Same Kidney Donor
Authors
Issue Date2003
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/35105
Citation
American Journal Of Hematology, 2003, v. 74 n. 4, p. 283-286 How to Cite?
AbstractPosttransplantation lymphoproliferative disease (PTLD) presenting as an Epstein-Barr-virus (EBV)-related nasal plasmacytoma developed in a renal-allograft recipient 13 years after transplantation. Systemic dissemination occurred despite immunosuppression withdrawal, surgery, irradiation, and chemotherapy. A nonmyeloablative hematopoietic-stem-cell-transplantation (HSCT) with peripheral blood HSC from the kidney donor was performed. With the onset of graft-versus-host disease, resolution of the systemic disease was demonstrated clinically and molecularly by serial quantification of plasma EBV-DNA. Isolated relapse occurred in the central nervous system (CNS), a known tumour sanctuary site, ultimately leading to death. Nonmyeloablative HSCT might be considered a cellular therapy for PTLD, but possible CNS relapse must be effectively tackled. © 2003 Wiley-Liss, Inc.
Persistent Identifierhttp://hdl.handle.net/10722/162734
ISSN
2015 Impact Factor: 5.0
2015 SCImago Journal Rankings: 1.761
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorAu, WYen_US
dc.contributor.authorLie, AKWen_US
dc.contributor.authorChan, ECen_US
dc.contributor.authorPang, Aen_US
dc.contributor.authorMa, SKen_US
dc.contributor.authorChoy, Cen_US
dc.contributor.authorKwong, YLen_US
dc.date.accessioned2012-09-05T05:22:52Z-
dc.date.available2012-09-05T05:22:52Z-
dc.date.issued2003en_US
dc.identifier.citationAmerican Journal Of Hematology, 2003, v. 74 n. 4, p. 283-286en_US
dc.identifier.issn0361-8609en_US
dc.identifier.urihttp://hdl.handle.net/10722/162734-
dc.description.abstractPosttransplantation lymphoproliferative disease (PTLD) presenting as an Epstein-Barr-virus (EBV)-related nasal plasmacytoma developed in a renal-allograft recipient 13 years after transplantation. Systemic dissemination occurred despite immunosuppression withdrawal, surgery, irradiation, and chemotherapy. A nonmyeloablative hematopoietic-stem-cell-transplantation (HSCT) with peripheral blood HSC from the kidney donor was performed. With the onset of graft-versus-host disease, resolution of the systemic disease was demonstrated clinically and molecularly by serial quantification of plasma EBV-DNA. Isolated relapse occurred in the central nervous system (CNS), a known tumour sanctuary site, ultimately leading to death. Nonmyeloablative HSCT might be considered a cellular therapy for PTLD, but possible CNS relapse must be effectively tackled. © 2003 Wiley-Liss, Inc.en_US
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/35105en_US
dc.relation.ispartofAmerican Journal of Hematologyen_US
dc.rightsAmerican Journal of Hematology. Copyright © John Wiley & Sons, Inc.-
dc.subject.meshAgeden_US
dc.subject.meshBrain Neoplasms - Secondaryen_US
dc.subject.meshDiagnosis, Differentialen_US
dc.subject.meshFatal Outcomeen_US
dc.subject.meshHematopoietic Stem Cell Transplantation - Methodsen_US
dc.subject.meshHerpesvirus 4, Humanen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney Transplantation - Adverse Effectsen_US
dc.subject.meshLymphoproliferative Disorders - Diagnosis - Etiology - Therapy - Virologyen_US
dc.subject.meshMaleen_US
dc.subject.meshNose Neoplasms - Etiology - Pathology - Therapy - Virologyen_US
dc.subject.meshPlasmacytoma - Diagnosisen_US
dc.subject.meshTissue Donorsen_US
dc.titleTreatment of Postrenal Transplantation Lymphoproliferative Disease Manifesting as Plasmacytoma with Nonmyeloablative Hematopoietic Stem Cell Transplantation from the Same Kidney Donoren_US
dc.typeArticleen_US
dc.identifier.emailKwong, YL:ylkwong@hku.hken_US
dc.identifier.authorityKwong, YL=rp00358en_US
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.doi10.1002/ajh.10417en_US
dc.identifier.pmid14635212-
dc.identifier.scopuseid_2-s2.0-0344012596en_US
dc.identifier.hkuros87926-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0344012596&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume74en_US
dc.identifier.issue4en_US
dc.identifier.spage283en_US
dc.identifier.epage286en_US
dc.identifier.isiWOS:000186921800012-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridAu, WY=7202383089en_US
dc.identifier.scopusauthoridLie, AKW=24284842400en_US
dc.identifier.scopusauthoridChan, EC=7401994120en_US
dc.identifier.scopusauthoridPang, A=7007044165en_US
dc.identifier.scopusauthoridMa, SK=37020910400en_US
dc.identifier.scopusauthoridChoy, C=7202840937en_US
dc.identifier.scopusauthoridKwong, YL=7102818954en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats